There have been 50 recent insider transactions recorded for Aprea Therapeutics, Inc. (APRE), including 47 buys and 2 sells. Total insider buying was valued at $933.51K and total insider selling at $47.13K.
Notable insiders with recent activity include Peters Richard, Hamill John P., Gilad Oren. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — APRE
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-03-31 |
Peters Richard |
Director |
Informative Buy |
123,915 |
$0.68 |
$84.63K |
123,915 |
| 2026-03-31 |
Hamill John P. |
Srvp/cfo/prin Fin & Acct Ofcr |
Informative Buy |
30,978 |
$0.68 |
$21.16K |
30,978 |
| 2026-03-12 |
Hamill John P. |
Srvp/cfo/prin Fin & Acct Ofcr |
RSU Award |
40,380 |
$0.77 |
$30.89K |
40,380 |
| 2026-03-12 |
Gilad Oren |
President/ceo |
RSU Award |
80,700 |
$0.77 |
$61.74K |
80,700 |
| 2026-01-30 |
Hamill John P. |
Srvp/cfo/prin Fin & Acct Ofcr |
Informative Buy |
5,700 |
$0.77 |
$4.36K |
5,700 |
| 2026-01-30 |
Gilad Oren |
President/ceo |
Informative Buy |
28,100 |
$0.77 |
$21.5K |
28,100 |
| 2025-12-10 |
Hamill John P. |
Srvp/cfo/prin Fin & Acct Ofcr |
Informative Buy |
5,000 |
$1.04 |
$5.2K |
5,000 |
| 2025-12-10 |
Duey Marc |
Director |
Informative Buy |
21,459 |
$1.04 |
$22.32K |
21,459 |
| 2025-12-10 |
Gilad Oren |
President/ceo |
Informative Buy |
21,459 |
$0.00 |
$2.15 |
21,459 |
| 2025-06-05 |
Henneman John B Iii |
Director |
RSU Award |
4,185 |
$1.81 |
$7.57K |
4,185 |
| 2025-06-05 |
Bizzari Jean-pierre |
Director |
RSU Award |
1,045 |
- |
- |
1,045 |
| 2025-06-05 |
Peters Richard |
Director |
RSU Award |
1,045 |
- |
- |
3,119 |
| 2025-06-05 |
Grissinger Michael |
Director |
RSU Award |
1,045 |
- |
- |
2,889 |
| 2025-06-05 |
Seizinger Bernd R. |
Director |
RSU Award |
4,185 |
$1.81 |
$7.57K |
4,185 |
| 2025-06-05 |
Gruia Gabriela |
Director |
RSU Award |
1,045 |
- |
- |
1,045 |
| 2025-06-05 |
Duey Marc |
Director |
RSU Award |
4,185 |
$1.81 |
$7.57K |
4,185 |
| 2025-06-05 |
Pamukcu Rifat |
Director |
RSU Award |
4,185 |
$1.81 |
$7.57K |
4,185 |
| 2025-04-03 |
Gilad Oren |
President/ceo |
Informative Buy |
3,003 |
$1.87 |
$5.62K |
343,123 |
| 2025-03-27 |
Hamill John P. |
Srvp/cfo/prin Fin & Acct Ofcr |
RSU Award |
13,460 |
$2.20 |
$29.61K |
13,460 |
| 2025-03-27 |
Gilad Oren |
President/ceo |
RSU Award |
26,900 |
$2.20 |
$59.18K |
26,900 |
| 2024-10-23 |
Gilad Oren |
President/ceo |
Informative Buy |
500 |
$3.92 |
$1.96K |
333,395 |
| 2024-10-18 |
Duey Marc |
Director |
Informative Sell |
6,462 |
$4.58 |
$29.58K |
233,651 |
| 2024-10-16 |
Duey Marc |
Director |
Informative Buy |
30,000 |
$4.39 |
$131.7K |
240,113 |
| 2024-10-15 |
Gilad Oren |
President/ceo |
Informative Buy |
250 |
$2.90 |
$725.00 |
332,895 |
| 2024-10-14 |
Gilad Oren |
President/ceo |
Informative Buy |
1,000 |
$2.59 |
$2.59K |
332,645 |
| 2024-10-14 |
Duey Marc |
Director |
Informative Buy |
190 |
$2.58 |
$490.20 |
210,113 |
| 2024-10-11 |
Seizinger Bernd R. |
Director |
Informative Buy |
10,000 |
$2.68 |
$26.8K |
44,730 |
| 2024-10-11 |
Hamill John P. |
Srvp/cfo/prin Fin & Acct Ofcr |
Informative Buy |
50 |
$2.46 |
$123.19 |
19,368 |
| 2024-10-10 |
Hamill John P. |
Srvp/cfo/prin Fin & Acct Ofcr |
Informative Buy |
450 |
$2.61 |
$1.17K |
19,318 |
| 2024-10-10 |
Gilad Oren |
President/ceo |
Informative Buy |
150 |
$2.54 |
$381.00 |
331,645 |
| 2024-06-20 |
Henneman John B Iii |
Director |
RSU Award |
4,185 |
$4.07 |
$17.03K |
4,185 |
| 2024-06-20 |
Peters Richard |
Director |
RSU Award |
1,045 |
- |
- |
2,074 |
| 2024-06-20 |
Grissinger Michael |
Director |
RSU Award |
1,045 |
- |
- |
1,844 |
| 2024-06-20 |
Seizinger Bernd R. |
Director |
RSU Award |
4,185 |
$4.07 |
$17.03K |
4,185 |
| 2024-06-20 |
Duey Marc |
Director |
RSU Award |
4,185 |
$4.07 |
$17.03K |
4,185 |
| 2024-06-20 |
Pamukcu Rifat |
Director |
RSU Award |
4,185 |
$4.07 |
$17.03K |
4,185 |
| 2024-05-01 |
Mirza Nadeem Q. |
Chief Medical Officer |
Disposition |
2,250 |
$7.80 |
$17.55K |
- |
| 2024-05-01 |
Mirza Nadeem Q. |
Chief Medical Officer |
RSU Award |
6,730 |
- |
- |
6,730 |
| 2024-03-28 |
Hamill John P. |
Srvp/cfo/prin Fin & Acct Ofcr |
RSU Award |
13,460 |
$6.69 |
$90.05K |
13,460 |
| 2024-03-28 |
Gilad Oren |
President, CEO |
RSU Award |
26,900 |
$6.69 |
$179.96K |
26,900 |
| 2024-03-13 |
Henneman John B Iii |
Director |
Informative Buy |
3,430 |
- |
- |
3,430 |
| 2024-03-13 |
Hamill John P. |
Srvp/cfo/prin Fin & Acct Ofcr |
Informative Buy |
505 |
- |
- |
505 |
| 2024-03-13 |
Seizinger Bernd R. |
Director |
Informative Buy |
3,430 |
- |
- |
3,430 |
| 2024-03-13 |
Gilad Oren |
President, CEO |
Informative Buy |
1,000 |
- |
- |
1,000 |
| 2023-08-23 |
Henneman John B Iii |
Director |
RSU Award |
500 |
- |
- |
1,279 |
| 2023-08-23 |
Bizzari Jean-pierre |
Director |
Unknown |
- |
- |
- |
- |
| 2023-08-23 |
Bizzari Jean-pierre |
Director |
RSU Award |
12,500 |
$3.65 |
$45.63K |
12,500 |
| 2023-08-23 |
Peters Richard |
Director |
RSU Award |
500 |
- |
- |
1,029 |
| 2023-08-23 |
Grissinger Michael |
Director |
RSU Award |
500 |
- |
- |
799 |
| 2023-08-23 |
Seizinger Bernd R. |
Director |
RSU Award |
2,000 |
$3.65 |
$7.3K |
2,000 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
